Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/26 17:41 | 3/9/26 | RXRX | Health | BioPrd | Biological Products, (No Diag | Khan Najat | UT | DO | CEO,P | 3 | S.d | -845 | 4.47 | 0 | -189 | 2,262 | D | |||||||||||||||
3/4/26 16:38 | 1/6/26 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 6 | S | -3,597 | 4.22 | 0 | -853 | 7,078 | D | ||||||||||||||||
2/19/26 19:30 | 1/20/26 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | D | 20 | S.dm | -9,548 | 5.37 | 0 | -1,777 | 1,273 | D | ||||||||||||||||
2/19/26 19:30 | 12/29/25 | RXRX | Health | BioPrd | Biological Products, (No Diag | Taylor Ben R | UT | O | CFO | 2 | S | -131 | 3.76 | 0 | -35 | 1,195 | D | |||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 1 | S.dm | -230 | 7.65 | 0 | -30 | 1,500 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |